Russia’s Sputnik V 91.6% effective in tests vs. symptomatic cases

Early into the Covid-19 pandemic, Russia was criticized for its early vaccine rollout.

But new data suggests its Sputnik V shots are 91.6% effective against symptomatic cases.

Let’s get the details from the company that invested in the vaccine’s development.

Kirill Dmitriev, CEO of the Russian direct investment fund, joins us live from Moscow.